FDA’s Light Touch With Medical Apps May Let Industry Bloom

Law360, New York (April 5, 2013, 5:03 PM EDT) -- The U.S. Food and Drug Administration’s hands-off approach to mobile medical apps is allowing potentially risky diagnostic tools to be sold to consumers without facing regulatory scrutiny, but stronger enforcement in the short term could stifle a promising and fast-growing field of health care technology, experts say.

Thousands of medical apps are available through Apple Inc.’s App Store and Google Inc.’s Google Play, and while most are innocuous — calorie counters, meditation music players and the like —  a sliver of the market is increasingly devoted...
To view the full article, register now.